IP Library Granted Patent US 7,105,051
Granted Patent B2
US 7,105,051 · App. 10/209,329 · Granted Sep 12, 2006

High quality colloidal nanocrystals and methods of preparing the same in non-coordinating solvents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,105,051
App. No.
10/209,329
Granted
Sep 12, 2006
Kind
B2
Abstract

The present invention provides substantially monodisperse colloidal nanocrystals and new preparative methods for the synthesis of substantially monodisperse colloidal nanocrystals. These synthetic methods afford the ability to tune nanocrystal size and size distribution. By using non-coordinating solvents in the synthetic process, these procedures constitute easier, less expensive, safer, and more environmentally “green” methods than those currently in use. This invention is generally applicable to any II–VI or III–V semiconductor material, and may be useful in generating metal-nonmetal compounds involving transition metals as well.

Claims (34)

1. A method of synthesizing colloidal nanocrystals, comprising:

a) combining a cation precursor, a ligand, and a non-coordinating solvent to form a cation-ligand complex; and

b) admixing an anion precursor with the cation-ligand complex at a temperature sufficient to form nanocrystals.

2. The method of claim 1 , wherein the cation precursor comprises a compound of a group II metal, a group III metal, a group IV metal, or a transition metal.

3. The method of claim 2 , wherein the group II metal is selected from Zn, Cd, or Hg.

4. The method of claim 2 , wherein the group III metal is selected from Al, Ga, or In.

5. The method of claim 2 , wherein the group IV metal is selected from Ge, Sn or Pb.

6. The method of claim 1 , wherein the cation precursor comprises a metal oxide, a metal carbonate, a metal bicarbonate, a metal sulfate, a metal sulfite, a metal phosphate, a metal phosphite, a metal halide, a metal carboxylate, a metal alkoxide, a metal thiolate, a metal amide, a metal imide, a metal alkyl, a metal aryl, a metal coordination complex, a metal solvate, or a metal salt.

7. The method of claim 1 , wherein the ligand is selected from a fatty acid, an amine, a phosphine, a phosphine oxide, a phosphonic acid or combination thereof.

8. The method of claim 7 , wherein the fatty acid is selected from decanoic acid, oleic acid, lauric acid, myristic acid, palmitic acid, or stearic acid.

9. The method of claim 1 , wherein the non-coordinating solvent has a melting point less than about 25° C. and a boiling point greater than about 250° C.

10. The method of claim 1 , wherein the non-coordinating solvent is octadecene.

11. The method of claim 1 , wherein the anion precursor is selected from an element, a covalent compound, or an ionic compound.

12. The method of claim 1 , wherein the anion precursor is selected from elemental S, elemental Se, elemental Te, selenium tributylphosphine, or tellurium tributylphosphine.

13. The method of claim 1 , wherein the anion precursor is combined with a non-coordinating solvent, a ligand, or a combination thereof prior to admixing with the cation-ligand complex.

14. The method of claim 1 , wherein the temperature sufficient to form nanocrystals is greater than about 200° C.

15. The method of claim 1 , wherein nanocrystals of CdS are formed.

16. The method of claim 1 , wherein nanocrystals of CdSe are formed.

17. The method of claim 1 , wherein nanocrystals of CdTe are formed.

18. The method of claim 1 , wherein nanocrystals of ZnSe are formed.

19. The method of claim 1 , wherein nanocrystals of InP are formed.

20. The method of claim 1 , wherein nanocrystals of InAs are formed.

21. The method of claim 1 , wherein the mean diameter of the nanocrystals is from about 1 nm to about 6 nm.

22. A method of synthesizing colloidal nanocrystals, comprising:

a) combining a cation precursor, a ligand, and a non-coordinating solvent to form a cation-ligand complex;

b) admixing an anion precursor with the cation-ligand complex at a first temperature sufficient to induce reaction between the cation-ligand complex and the anion precursor; and

c) adjusting the temperature of the mixture to a second temperature sufficient to form nanocrystals of the reaction product.

23. The method of claim 22 , wherein the anion precursor is combined with a non-coordinating solvent, a ligand, or a combination thereof prior to admixing with the cation-ligand complex.

24. The method of claim 22 , wherein the cation precursor is CdO, the ligand is oleic acid, the non-coordinating solvent is octadecene, and the anion precursor is elemental sulfur.

25. The method of claim 22 , wherein the cation precursor is CdO, the ligand is oleic acid, the non-coordinating solvent is octadecene, and the anion precursor is selenium tributylphosphine.

26. The method of claim 22 , wherein the cation precursor is CdO, the ligand is oleic acid, the non-coordinating solvent is octadecene, and the anion precursor is tellurium tributylphosphine.

27. The method of claim 22 , wherein the cation precursor is Zn(acetate) 2 , the ligand is oleic acid, the non-coordinating solvent is octadecene, and the anion precursor is elemental selenium tributylphosphine.

28. The method of claim 22 , wherein the cation precursor is In(acetate) 3 , the ligand is selected from myristic acid or palmitic acid, the non-coordinating solvent is octadecene, and the anion precursor is P(SiMe 3 ) 3 .

29. The method of claim 22 , wherein the cation precursor is In(acetate) 3 , the ligand is selected from myristic acid or palmitic acid, the non-coordinating solvent is octadecene, and the anion precursor is As(SiMe 3 ) 3 .

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 22, 2006
From: UNIVERSITY OF ARKANSAS
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 018546/0490 →
SECURITY AGREEMENT Recorded Feb 16, 2005
From: QUANTUM DOT CORPORATION
To: INSTITUTIONAL VENTURE PARTNERS VII, L.P.; INSTITUTIONAL VENTURE MANAGEMENT VII, L.P.; ABINGWORTH BIOVENTURES IIA LP; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP2; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP3; SV NOMINEES LIMITED ON BEHALF OF SCHRODER VENTURES INVESTMENTS LIMITED; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II GROUP CO-INVESTMENT SCHEME; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II STRATEGIC PARTNERS LP; FRAZIER HEALTHCARE III, L.P.; FRAZIER AFFILIATES III, L.P.; BB BIOVENTURES L.P.; MPM ASSET MANAGEMENT INVESTORS 2000 A LLC; MPM BIOVENTURES PARALLEL FUND, L.P.
Reel/Frame 015687/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2002
From: PENG, XIAOGANG; YU, WEIYONG; BATTAGLIA, DAVID
To: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, THE
Reel/Frame 013426/0544 →